These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 190412

  • 1. Immunosuppression in mice after inoculation with 334C, a murine lymphatic leukemia-inducing virus.
    Schenk PJ, Buffett RF.
    J Natl Cancer Inst; 1977 Mar; 58(3):665-71. PubMed ID: 190412
    [Abstract] [Full Text] [Related]

  • 2. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H, Kateley JR.
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [Abstract] [Full Text] [Related]

  • 3. Immunocytes and leukemia virus infection: effects on bone marrow and thymus cell responses and interactions.
    Ceglowski WS, LaBadie GU, Friedman H.
    Adv Exp Med Biol; 1973 May; 29(0):499-505. PubMed ID: 4368788
    [No Abstract] [Full Text] [Related]

  • 4. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G, Rossi GB, Del Gobbo V, Accinni L, Ranucci A, Titti F, Premrov MG, Garaci E.
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppression by 334C murine leukemia virus: viral specificity and the activation of immunosuppressive effects during cloned viral leukemogenesis.
    Robinson MK, Manly KF, Evans MJ.
    J Immunol; 1980 Mar; 124(3):1022-7. PubMed ID: 6244346
    [No Abstract] [Full Text] [Related]

  • 6. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
    Cerny J, Waner EB.
    J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
    Kumar V, Caruso T, Bennett M.
    J Exp Med; 1976 Apr 01; 143(4):728-40. PubMed ID: 1082914
    [Abstract] [Full Text] [Related]

  • 8. Suppression of in vitro antibody response by spleen cells of mice infected with Friend-associated lymphatic leukemia virus.
    Bendinelli M, Matteucci D, Toniolo A, Friedman H.
    Infect Immun; 1979 Apr 01; 24(1):1-6. PubMed ID: 222677
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J, Stiller RA.
    J Immunol; 1975 Oct 01; 115(4):943-9. PubMed ID: 170339
    [Abstract] [Full Text] [Related]

  • 10. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP, Good RA.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [Abstract] [Full Text] [Related]

  • 11. Leukemogenesis in vitro induced by thymus epithelial reticulum cells transmitting murine leukemia viruses.
    Haas M, Sher T, Smolinsky S.
    Cancer Res; 1977 Jun 01; 37(6):1800-7. PubMed ID: 192463
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ, Howe ML.
    J Immunol; 1979 May 01; 122(5):1874-80. PubMed ID: 221580
    [Abstract] [Full Text] [Related]

  • 13. Reversal of immunosuppression induced by murine leukemia viruses.
    Bendinelli M, Toniolo A.
    Ann N Y Acad Sci; 1976 May 01; 276():431-41. PubMed ID: 1071970
    [Abstract] [Full Text] [Related]

  • 14. Divergence between immunosuppression and immunocompetence during virus-induced leukemogenesis.
    Cerny J, McAlack RF, Geglowski WS, Friedman H.
    Proc Natl Acad Sci U S A; 1971 Aug 01; 68(8):1862-5. PubMed ID: 4942915
    [Abstract] [Full Text] [Related]

  • 15. Association of endogenous retroviruses with radiation-induced leukemias of BALB/c mice.
    Ellis RW, Stockert E, Fleissner E.
    J Virol; 1980 Feb 01; 33(2):652-60. PubMed ID: 6157834
    [Abstract] [Full Text] [Related]

  • 16. Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study.
    Avidan N, Sieck TG, Blank KJ.
    Clin Immunol Immunopathol; 1997 Dec 01; 85(3):282-8. PubMed ID: 9400628
    [Abstract] [Full Text] [Related]

  • 17. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J, Haverman J, Nusse R, van Blitterswijk WJ, Cleton FJ, Hageman PC, van Nie P, Calafat J.
    J Natl Cancer Inst; 1975 Jun 01; 54(6):1323-33. PubMed ID: 166186
    [Abstract] [Full Text] [Related]

  • 18. B and T lymphocyte activation by murine leukemia virus infection.
    Bendinelli M, Friedman H.
    Adv Exp Med Biol; 1979 Jun 01; 121B():91-7. PubMed ID: 317564
    [Abstract] [Full Text] [Related]

  • 19. Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.
    Cross SS, Brede G, Tucker HS, Maloney M, Montour JL, Hard RC.
    Infect Immun; 1983 Aug 01; 41(2):570-7. PubMed ID: 6135664
    [Abstract] [Full Text] [Related]

  • 20. Immunofluorescence and histologic studies of virus-induced murine lymphocytic leukemias.
    Dawson PJ, Dresler SL, Fieldsteel AH.
    J Natl Cancer Inst; 1976 May 01; 56(5):1047-50. PubMed ID: 186613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.